Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 23.06
-0.10 (-0.43%)
Nov 18, 2025, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 9.4 billion as of November 17, 2025. Its market cap has increased by 113.65% in one year.
Market Cap
9.40B
Enterprise Value
9.59B
Revenue
709.13M
Ranking
n/a
PE Ratio
145.91
Stock Price
23.06
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 9.40B, a decrease of -41.86%. That is a compound annual growth rate of -11.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 9.40B | 118.49% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 417.34B |
| WuXi AppTec | 282.16B |
| Shenzhen Mindray Bio-Medical Electronics | 251.19B |
| Sichuan Biokin Pharmaceutical | 153.43B |
| Aier Eye Hospital Group | 113.87B |
| Shanghai United Imaging Healthcare | 112.24B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.07B |
| Yunnan Baiyao Group Co.,Ltd | 101.10B |